HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara Savoldo Selected Research

Vaccines

1/2016Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies.
1/2013Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara Savoldo Research Topics

Disease

84Neoplasms (Cancer)
01/2024 - 01/2002
13Hematologic Neoplasms (Hematological Malignancy)
12/2023 - 09/2008
12Neuroblastoma
01/2024 - 11/2008
10Hodgkin Disease (Hodgkin's Disease)
03/2024 - 10/2007
10Lymphoma (Lymphomas)
03/2024 - 05/2011
8Graft vs Host Disease (Graft-Versus-Host Disease)
06/2015 - 08/2009
5Melanoma (Melanoma, Malignant)
01/2022 - 09/2008
5Infections
06/2015 - 08/2009
4Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2024 - 12/2006
4Leukemia
01/2024 - 11/2011
4Glioblastoma (Glioblastoma Multiforme)
12/2022 - 01/2018
4Multiple Myeloma
03/2019 - 07/2002
4Virus Diseases (Viral Diseases)
04/2014 - 09/2005
3Cytokine Release Syndrome
01/2023 - 06/2015
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 12/2006
3Testicular Neoplasms (Testicular Cancer)
09/2014 - 09/2008
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2006 - 01/2002
2Brain Neoplasms (Brain Tumor)
12/2022 - 01/2022
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2022
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 11/2013
2Breast Neoplasms (Breast Cancer)
01/2020 - 06/2007
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019 - 01/2019
2B-Cell Lymphoma (Lymphoma, B Cell)
05/2011 - 12/2006
2Inflammation (Inflammations)
01/2010 - 07/2009
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1Retinoblastoma (Glioblastoma, Retinal)
10/2020
1Retinal Neoplasms
10/2020
1Triple Negative Breast Neoplasms
01/2020
1Sarcoma (Soft Tissue Sarcoma)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
11/2019
1Adenocarcinoma
11/2019
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2018
1Embryonal Carcinoma
10/2018
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2017
1Lymphopenia (Lymphocytopenia)
01/2016

Drug/Important Bio-Agent (IBA)

54Chimeric Antigen ReceptorsIBA
01/2024 - 06/2007
33AntigensIBA
01/2022 - 07/2002
8CytokinesIBA
11/2021 - 05/2006
8Interleukin-15 (Interleukin 15)IBA
11/2020 - 10/2007
7Interleukin-2 (IL2)IBA
06/2014 - 06/2007
5Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2009
4EpitopesIBA
10/2019 - 12/2011
3Monoclonal AntibodiesIBA
12/2023 - 06/2007
3Ki-1 AntigenIBA
01/2022 - 06/2009
3fludarabineIBA
11/2020 - 06/2015
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018 - 06/2015
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018 - 01/2015
3CD19-specific chimeric antigen receptorIBA
01/2016 - 10/2013
3AutoantigensIBA
01/2015 - 07/2002
3Interleukin-7 (Interleukin 7)IBA
06/2014 - 05/2009
3Antiviral Agents (Antivirals)IBA
10/2013 - 04/2010
2Neoplasm Antigens (Tumor Antigens)IBA
12/2023 - 09/2014
2Messenger RNA (mRNA)IBA
01/2022 - 05/2015
2Immunoglobulins (Immunoglobulin)IBA
11/2021 - 12/2006
2InterleukinsIBA
10/2020 - 01/2013
2GD2 gangliosideIBA
10/2020 - 09/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2018
2AntibodiesIBA
01/2019 - 09/2009
2CD19 AntigensIBA
01/2017 - 05/2011
2VaccinesIBA
01/2016 - 01/2013
2AP 1903 reagentIBA
06/2015 - 11/2011
2SurvivinIBA
01/2015 - 12/2011
2Viral AntigensIBA
10/2013 - 01/2013
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2011 - 08/2009
2ChemokinesIBA
01/2010 - 06/2009
2Chemokine ReceptorsIBA
01/2010 - 06/2009
1Interleukin-12 (IL 12)IBA
01/2024
1Caspase 9IBA
12/2023
1Anaplastic Lymphoma KinaseIBA
12/2023
1tazemetostatIBA
01/2022
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1CCR2 ReceptorsIBA
01/2022
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
11/2021
1FibrinIBA
10/2021
1Surface Antigens (Surface Antigen)IBA
01/2021
1HydrogelsIBA
10/2020
1ErbB Receptors (EGF Receptor)IBA
01/2020
1Interferon-gamma (Interferon, gamma)IBA
01/2020
1Interleukin-23 (Interleukin 23)IBA
01/2020
1Interleukin-18 (Interleukin 18)IBA
01/2020
1Cetuximab (Erbitux)FDA Link
01/2020
1Panitumumab (Vectibix)FDA Link
01/2020
1Cancer VaccinesIBA
10/2019
1Programmed Cell Death 1 ReceptorIBA
01/2019
1I-E-antigenIBA
10/2018
1chondroitin sulfate proteoglycan 4IBA
01/2018
1Immune Checkpoint InhibitorsIBA
01/2017

Therapy/Procedure

30Therapeutics
03/2024 - 06/2005
28Immunotherapy
01/2024 - 01/2002
6Stem Cell Transplantation
03/2024 - 01/2002
4Transplantation
03/2024 - 08/2009
3Drug Therapy (Chemotherapy)
12/2019 - 11/2012
3Hematopoietic Stem Cell Transplantation
01/2014 - 08/2009
3Liver Transplantation
11/2006 - 09/2005
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018 - 01/2018
1Salvage Therapy
03/2024
1Intravenous Administration
10/2021
1Injections
10/2020